AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
InhaleRx Shares Surge by 36% on Significant Funding Agreement Announcement
October 18, 2024 05:11 PM AEDT| By Team Kalkine MediaHighlights,The company has secured funding of up to $38.5 million from Clendon Biotech Capital.,Funding to support IRX-211 (for breakthrough cancer pain) and IRX-616a (for panic disorder).,Shares surged 36% following the announcement, reflecting stro...
Telix Pharmaceuticals Announces Proposed Nasdaq Listing
October 18, 2024 05:04 PM AEDT| By Team Kalkine MediaHighlights,Telix to list ADSs on Nasdaq under ticker,"TLX",.,Part of Telix's plan to broaden its global investor base and enhance its U.S. operations.,Telix will continue to be primarily listed on the ASX.,Shares of Telix Pharmaceuticals Limited (ASX...
Tryptamine Therapeutics Completes Phase 1b Trial for Psilocin Formulation TRP-8803
October 18, 2024 04:12 PM AEDT| By Team Kalkine MediaHighlights,Tryptamine Therapeutics completes safety evaluation of TRP-8803.,The trial showed positive safety results with IV-infused psilocin treatment.,The company now looks toward further clinical studies with Phase 2 trials.,Tryptamine Therapeutic...
Telix (ASX:TLX) Targets Sales Growth with New Cancer Treatments and US Listing
October 18, 2024 03:47 PM AEDT| By Team Kalkine MediaHighlights,Telix Pharmaceuticals plans to double sales with new cancer treatment products.,Illuccix sales expected to expand with upcoming regulatory approvals.,Nasdaq listing planned without raising new capital or issuing shares.,Telix Pharmaceutica...
Latin Resources Advances at Colina Lithium Project with Key Achievements
October 18, 2024 03:43 PM AEDT| By Team Kalkine MediaHighlights:,Latin Resources Limited is focused on advancing its Colina Lithium Project in Brazil, having defined a maiden mineral resource of 45.2 million tonnes at 1.32% lithium oxide.,A significant acquisition by Pilbara Minerals will see Latin Res...
InhaleRX Raises $38.5 Million from Clendon for Biotech Initiatives
October 18, 2024 03:22 PM AEDT| By Team Kalkine MediaHighlights:,InhaleRX initiates clinical trials for cannabis-based compounds aimed at pain management and mental health.,The company has secured significant funding from Victorian VC firm Clendon to support its research and development efforts.,Inhale...
Tryptamine Therapeutics Marks Safety Milestone in Psilocin IV Infusion Trials
October 18, 2024 11:58 AM AEDT| By Team Kalkine MediaHighlights,Tryptamine Therapeutics Ltd achieves safety milestone in psilocin IV infusion trial.,TRP-8803,deemed,safe after Phase 1b study involving 11 participants.,Further trials planned, with preparations for a Phase 2 study underway.,Tryptamine Th...
Telix Pharmaceuticals' Quarterly Revenue Exceeds AU$200M Mark
October 18, 2024 11:42 AM AEDT| By Team Kalkine MediaHighlights,Telix,Pharmaceuticals reports AU$201M in quarterly revenue,.,Sales growth driven by,prostate,cancer imaging product,,Illuccix,.,Company expects full-year revenue to reach between AU$745M to AU$776M.,Telix Pharmaceuticals,(ASX:TLX),has repo...
Vitura Health Limited's (ASX:VIT) Share Price Climbs, but Revenue Challenges Remain
October 18, 2024 11:05 AM AEDT| By Team Kalkine MediaHighlights,Vitura,Health Limited shows a significant rise in share price despite ongoing challenges.,Recent revenue performance and price-to-sales ratio,indicate,market skepticism.,Company’s medium-term growth contrasts with higher industry expectati...
Pro Medicus (ASX:PME) A Deep Dive into Financial Performance and Growth
October 17, 2024 06:40 PM AEDT| By Team Kalkine MediaHighlights,Pro Medicus reported significant profit growth with solid financial health.,The company’s radiology IT software and Visage platform play a key role in the healthcare sector.,PME has a strong return on equity and minimal debt, positioning i...
Frameworks for Valuing ASX and RMD Shares
October 17, 2024 03:57 PM AEDT| By Team Kalkine MediaHighlights:,ASX Limited has experienced a 4.9% increase in share price since the beginning of 2024, reflecting positive market sentiment.,ResMed CDI is currently trading approximately 66.9% above its 52-week low, indicating a potential recovery in s...
Six Critical Metrics Employed in PME Share Valuation
October 17, 2024 03:30 PM AEDT| By Team Kalkine MediaHighlights:,Pro Medicus Limited has experienced a remarkable share price increase of 97.13% in 2024, highlighting strong market performance.,The company reports impressive revenue and profit growth, with a compound annual growth rate (CAGR) of 33.4%...
Anteris Technologies Secures R&D Tax Refund for Medical Innovations
October 17, 2024 01:13 PM AEDT| By Team Kalkine MediaHighlights,Anteris Technologies receives a significant R&D tax refund.,The company focuses on advancing heart-related technologies.,Funding supports development and clinical trials for innovative devices.,Anteris Technologies Ltd,(ASX:AVR),has been a...
Five-Year Extension of $32 Million Contract for RIS Technology Awarded to Pro Medicus
October 16, 2024 10:59 PM AEDT| By Team Kalkine MediaHighlights:,Contract Extension:,Pro Medicus Ltd has secured a five-year contract extension valued at a minimum of $32 million with a prominent Australian Radiology Network.,Technological Leadership:,The contract pertains to PME’s Radiology Informatio...
PME and BHP Share Prices Acknowledged as Noteworthy
October 16, 2024 10:27 PM AEDT| By Team Kalkine MediaHighlights:,Pro Medicus Growth:,Pro Medicus Limited (ASX: PME) has experienced a notable 93% increase in its share price since the start of 2024, reflecting strong market confidence.,BHP’s Stability:,BHP Group Ltd (ASX: BHP) is currently 14.4% below...
EBR Systems Submits NTAP Application for WiSE CRT System
October 16, 2024 05:41 PM AEDT| By Team Kalkine MediaHIGHLIGHTS,EBR Systems has submitted an application for New Technology Add-On Payment (NTAP) to the Centers for Medicare & Medicaid Services (CMS) for its WiSE CRT System.,To qualify for NTAP, technologies must meet three criteria: being new, having...
Pro Medicus Secures Major Contract Extension with Australian Radiology Network
October 16, 2024 12:24 PM AEDT| By Team Kalkine MediaHighlights,Pro Medicus signs a five-year contract extension valued at $32 million.,The extension strengthens its relationship with a major Australian radiology network.,The contract highlights Pro Medicus' continued growth in health imaging technolog...
Immuron Ltd Records Strong Sales Growth for Travelan in Latest Quarter
October 15, 2024 06:45 PM AEDT| By Team Kalkine MediaHighlights,Travelan sales grew by 13% in the September quarter.,Australia saw a 3% rise in Travelan sales.,North American sales surged by 48%, showing significant market expansion.,Immuron Ltd (ASX:IMC) has reported solid sales growth for its immune...
Share Consolidations and Clinical Advancements in ASX Companies
October 15, 2024 04:14 PM AEDT| By Team Kalkine MediaHighlights,Invion and Wellnex Life implement share consolidations.,Invion begins trial for non-melanoma skin cancer, while Wellnex migrates to the London Stock Exchange.,Artrya progresses toward US FDA approval for its cardiovascular AI device.,Share...
Lumos Diagnostics Holdings (ASX:LDX) Shows Impressive Surge, But Challenges Remain
October 14, 2024 03:24 PM AEDT| By Team Kalkine MediaHighlights,Lumos Diagnostics Holdings surged 35% despite lagging industry trends.,The company's revenue has declined over the past three years,,impacting,its valuation.,Market sentiment,remains,cautious due to lower growth expectations.,Lumos Diagnos...
Advertise your brand on Kalkine Media